# Xiaochuang Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xiaochuang-medical

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.xiaochuangmed.com
- Latest round: Angel (May 26, 2026)
- Investors on record: 2

## About

Based in Suzhou, China and founded in 2024, Suzhou Xiaochuang Medical Technology Co., Ltd., dba Xiaochuang Medical, is a company specializing in developing and manufacturing medical treatment devices relying on duodenal pulsed electric field ablation (PFA) and other technologies.

In May 2026, Xiaochuang Medical raised an Angel+ funding led byr Oriza Holdings, with participation from Suzhou High-tech Zone Science and Technology Angel Fund and Shanghai Hongye.

Xiaochuang Medical focuses on developing medical devices for treating digestive and metabolic diseases. The company's main products include pulsed electric field ablation equipment that improves the sensitivity of liver to insulin based on irreversible electroporation (IRE) mechanism, and disposable digestive tract ablation catheters which can be used in combination with pulsed electric field ablation equipment for more effective treatment of type 2 diabetes.

The company generates revenue by developing, manufacturing and selling PFA medical devices and related supplies.

The company will use the angel funding in November 2024 to increase its investment in core technology R&D, improve its product portfolio, accelerate the clinical translation and commercialization of its products, and strive to create medical products with core competitiveness.

## Funding rounds

- Angel, May 26, 2026 — Oriza Holdings, Suzhou High-tech Zone Science and Technology Angel Fund

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Angel
- Suzhou High-tech Zone Science and Technology Angel Fund — Angel